Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06739616Not ApplicableCompleted

Expanding Interventions for Automatically Maintained SIB

Role: collaborator

NCT04078061Not ApplicableCompleted

Comparative Effectiveness of EIBI and Adaptive ABA for Children With Autism

Role: collaborator

NCT04533607Not ApplicableUnknown

Modular Approach for Autism Programs in Schools

Role: lead

NCT03573128Not ApplicableCompleted

Development and Pilot Testing of the Students With Autism Accessing General Education (SAAGE) Model

Role: collaborator

All 4 trials loaded